BRCA2 c.3051_3052insG ;(p.K1018Efs*4)

Variant ID: 13-32911543-C-CG

NM_000059.3(BRCA2):c.3051_3052insG;(p.K1018Efs*4)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab.

Cold Spring Harbor Molecular Case Studies
Alnajar, Hussein H; Ravichandran, Hiranmayi H; Figueiredo Rendeiro, André A; Ohara, Kentaro K; Al Zoughbi, Wael W; Manohar, Jyothi J; Greco, Noah N; Sigouros, Michael M; Fox, Jesse J; Muth, Emily E; Angiuoli, Samuel S; Faltas, Bishoy B; Shusterman, Michael M; Sternberg, Cora N CN; Elemento, Olivier O; Mosquera, Juan Miguel JM
Publication Date: 2022-04

Variant appearance in text: BRCA2: K1018Efs
PubMed Link: 35483877
Variant Present in the following documents:
  • MCS006151Aln.pdf
View BVdb publication page